Micro Labs Limited — Febuxostat Exporter Profile
Indian Pharmaceutical Exporter · #15 for Febuxostat · $392.0K export value · DGFT Verified
Micro Labs Limited is the #15 Indian exporter of Febuxostat with $392.0K in export value and 97 verified shipments. Micro Labs Limited holds a 0.8% market share in Febuxostat exports across 10 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Febuxostat Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Febuxostat?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $85.1K | 6 | 19.0% |
| UGANDA | $58.1K | 21 | 13.0% |
| FRANCE | $53.8K | 18 | 12.0% |
| PHILIPPINES | $52.7K | 3 | 11.8% |
| KENYA | $46.7K | 8 | 10.5% |
| ZAMBIA | $34.3K | 15 | 7.7% |
| RWANDA | $32.3K | 16 | 7.2% |
| IRAQ | $29.5K | 2 | 6.6% |
| SRI LANKA | $26.6K | 2 | 6.0% |
| MALDIVES | $23.9K | 7 | 5.3% |
Micro Labs Limited exports Febuxostat to 11 countries. The largest destination is NIGERIA accounting for 19.0% of Micro Labs Limited's Febuxostat shipments, followed by UGANDA (13.0%) and FRANCE (12.0%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Febuxostat from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $85.1K | 6 |
| BROWN AND BURK PHILIPPINES INC | PHILIPPINES | $52.7K | 3 |
| M/S LABOREX KENYA LIMITED | KENYA | $40.4K | 7 |
| E.P.DIS | FRANCE | $33.2K | 11 |
| HAWKARY PHARMACEUTICAL COMPANY# | IRAQ | $29.5K | 2 |
| MICRO HEALTHCARE PRIVATE LIMITED | SRI LANKA | $26.6K | 2 |
| PHILLIPS PHARMACEUTICALS (UGANDA) | UGANDA | $22.8K | 6 |
| PHILLIPS PHARMACEUTICALS | ZAMBIA | $21.9K | 11 |
| WESSEX PHARMACEUTICALS (RWANDA) | RWANDA | $17.5K | 9 |
| PHILLIPS PHARMACEUTICALS(UGANDA) | UGANDA | $16.6K | 6 |
Micro Labs Limited supplies Febuxostat to 30 buyers globally. The largest buyer is MICRO NOVA PHARMACEUTICALS IND (NIGERIA), followed by BROWN AND BURK PHILIPPINES INC (PHILIPPINES) and M/S LABOREX KENYA LIMITED (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Febuxostat Export Value and How Much Does Micro Labs Limited Contribute?
India exported $24.2M worth of Febuxostat through 3,494 shipments from 182 suppliers to 91 countries, serving 421 buyers globally. Micro Labs Limited contributes $392.0K to this total, accounting for 0.8% of India's Febuxostat exports. Micro Labs Limited ships Febuxostat to 11 countries through 30 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Febuxostat Exports?
Micro Labs Limited's average Febuxostat shipment value is $4.0K per consignment, based on 97 shipments totaling $392.0K. The largest destination is NIGERIA (19.0% of Micro Labs Limited's Febuxostat exports).
How Does Micro Labs Limited Compare to Other Indian Febuxostat Exporters?
Micro Labs Limited ranks #15 among 182 Indian Febuxostat exporters with a 0.8% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($6.0M), AJANTA PHARMA LIMITED ($4.5M), ALEMBIC PHARMACEUTICALS LIMITED ($2.8M). Micro Labs Limited processed 97 shipments to 10 destination countries.
What Febuxostat Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MEBUX 40 Febuxostat Tablets 40mg 3X10S | $33.6K | 2 |
| RUXTA 40 Febuxostat 40mg Tablets 3X10S | $25.4K | 1 |
| MEBUX 40 (FEBUXOSTAT TABLETS 40MG)( 3X10`S ) ( QTY- 12687.000 )TAX INV NO: 701209848/24.02.2025 | $18.0K | 1 |
| RUXTA 80 Febuxostat Tablets 80mg 3X10 s X 6392 Tablets | $14.3K | 1 |
| XANURIX 40 FEBUXOSTAT TABLETS 40MG 3X10 S QTY 3360 000 TAX INV NO 701210168 03 05 2025 | $14.1K | 2 |
| RUXTA 80 Febuxostat Tablets 80mg 3X10S QTY- 6366.000 | $13.6K | 1 |
| RUXTA 80 (FEBUXOSTAT TABLETS 80MG) 3 X 1 | $13.4K | 1 |
| XANURIX 40 Febuxostat Tablets 40mg 3X10S QTY- 4320.000 | $13.3K | 1 |
| XANURIX 40 Batch No: FSAH0016 Febuxostat Tablets 40mg 3X10S QTY- 4320.000 | $13.3K | 1 |
| MEBUX 40 (FEBUXOSTAT TABLETS 40MG) (3X10s) - TAX INVOICE NO: 701209681 DT: 06.01.2025 | $12.8K | 1 |
Micro Labs Limited exports 84 distinct Febuxostat formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEBUX 40 Febuxostat Tablets 40mg 3X10S with 2 shipments worth $33.6K.
Regulatory Requirements: Exporting Febuxostat to Key Markets
What Micro Labs Limited must comply with to export Febuxostat to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Febuxostat Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | MYLAN LABORATORIES LIMITED | $414.0K | 16 | 5 | $25.9K |
| 14 | ZYDUS LIFESCIENCES LIMITED | $398.4K | 22 | 5 | $18.1K |
| 15 | MICRO LABS LIMITED ★ | $392.0K | 97 | 10 | $4.0K |
Micro Labs Limited ranks #15 among 182 Indian Febuxostat exporters. Average shipment value of $4.0K compared to the market average of $132.8K. The closest competitors by value are MYLAN LABORATORIES LIMITED and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Febuxostat Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 639 | 18.3% |
| SAHAR AIR | 615 | 17.6% |
| DELHI AIR | 387 | 11.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 351 | 10.0% |
| NHAVA SHEVA SEA (INNSA1) | 145 | 4.1% |
| HYDERABAD ICD (INSNF6) | 98 | 2.8% |
| HYDERABAD AIR | 96 | 2.7% |
| Bombay Air | 84 | 2.4% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Febuxostat Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Febuxostat, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 100 individual customs records matching Micro Labs Limited exporting Febuxostat, covering 84 formulations to 11 countries via 30 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 91+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Febuxostat Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Febuxostat exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Febuxostat Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Febuxostat. For current shipment-level data, contact TransData Nexus.